Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

A joint team of food safety and police officials raided a factory in Dehradun allegedly manufacturing fake medicines of leading pharmaceutical companies.

Lucknow: A joint team of the Uttar Pradesh Food Safety and Drug Administration (FSDA) and the Ghaziabad Crime Branch has busted an alleged fake medicine manufacturing unit in Dehradun, seizing spurious medicines estimated to be worth Rs 5 to 7 crore, officials said.

The raid was conducted at a factory located in the Devi Pur area on New Highway Road in Dehradun, where fake medicines bearing the names of several leading pharmaceutical companies were allegedly being manufactured.

According to officials, the unit was producing spurious medicines using the names of companies including Cipla, Lupin, Dr Reddy’s Laboratories, Elder, Micro Labs, Mankind Pharma, Intas Pharmaceuticals, Abbott, Sun Pharma, Aristo Pharmaceuticals, Macleods Pharmaceuticals and Zydus Lifesciences. The medicines were allegedly intended to be sold in the market as genuine products.

Officials said the seizure is estimated to be worth between Rs 5 crore and Rs 7 crore. Counting, verification and seizure of the seized stock are underway.

FSDA Joint Commissioner Brajesh Kumar said the raid followed intelligence gathered during an ongoing crackdown on spurious and illegal medicines in Uttar Pradesh. He said earlier raids in districts including Lucknow and Ghaziabad had led officials to the Dehradun unit.

Preliminary investigation has revealed that the fake medicines manufactured at the factory were being supplied to several districts of Uttar Pradesh through an organised interstate distribution network, officials said.

Further investigation is underway to identify those involved in the racket and trace the supply chain.

Related Posts

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry